BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 1697875)

  • 1. Identification of the anti-CD3-unresponsive subpopulation of CD4+, CD45RA+ peripheral T lymphocytes.
    Koulova L; Yang SY; Dupont B
    J Immunol; 1990 Oct; 145(7):2035-43. PubMed ID: 1697875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK; Doyle LV
    J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged expression of high molecular mass CD45RA isoform during the differentiation of human progenitor thymocytes to CD3+ cells in vitro.
    Deans JP; Wilkins JA; Caixia S; Pruski E; Pilarski LM
    J Immunol; 1991 Dec; 147(12):4060-8. PubMed ID: 1836475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
    Hirokawa M; Gray JD; Takahashi T; Horwitz DA
    J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of cytokines on proliferative response of human CD4+ T lymphocyte subsets stimulated via T cell receptor-CD3 complex.
    Wasik MA; Morimoto C
    J Immunol; 1990 May; 144(9):3334-40. PubMed ID: 1691754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
    Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
    J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential in vitro activation of CD8-CD4+ and CD4-CD8+ T lymphocytes by combinations of anti-CD2 and anti-CD3 antibodies.
    Yang SY; Rhee S; Welte K; Dupont B
    J Immunol; 1988 Apr; 140(7):2115-20. PubMed ID: 3258328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes.
    Damle NK; Klussman K; Linsley PS; Aruffo A
    J Immunol; 1992 Apr; 148(7):1985-92. PubMed ID: 1372018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional.
    Pierres A; Cerdan C; Lopez M; Mawas C; Olive D
    J Immunol; 1990 Feb; 144(4):1202-7. PubMed ID: 1968076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CD27 expression on subsets of mature T-lymphocytes.
    Hintzen RQ; de Jong R; Lens SM; Brouwer M; Baars P; van Lier RA
    J Immunol; 1993 Sep; 151(5):2426-35. PubMed ID: 7689607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ localization of CD45 isoforms in the human thymus indicates a medullary location for the thymic generative lineage.
    Gillitzer R; Pilarski LM
    J Immunol; 1990 Jan; 144(1):66-74. PubMed ID: 1688577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD45 isoform expression during T cell development in the thymus.
    Fujii Y; Okumura M; Inada K; Nakahara K; Matsuda H
    Eur J Immunol; 1992 Jul; 22(7):1843-50. PubMed ID: 1378021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets.
    Huet S; Boumsell L; Dausset J; Degos L; Bernard A
    Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells.
    Wallace DL; Beverley PC
    Immunology; 1990 Mar; 69(3):460-7. PubMed ID: 1968889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD45R+ cells are preferentially activated through the CD2 pathway.
    Matsuyama T; Anderson P; Daley JF; Schlossman S; Morimoto C
    Eur J Immunol; 1988 Sep; 18(9):1473-6. PubMed ID: 2458944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
    Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
    J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR-independent activation of human CD4+ 45RO- T cells by anti-CD28 plus IL-2: Induction of clonal expansion and priming for a Th2 phenotype.
    Brinkmann V; Kinzel B; Kristofic C
    J Immunol; 1996 Jun; 156(11):4100-6. PubMed ID: 8666775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line.
    Rothstein DM; Yamada A; Schlossman SF; Morimoto C
    J Immunol; 1991 Feb; 146(4):1175-83. PubMed ID: 1671403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.